<div id="readability-page-1">Align Technology (NASDAQ:ALGN - Get Free Report) had its target price raised by equities researchers at Evercore ISI from $180.00 to $200.00 in a research note issued on Thursday,MarketScreener reports. The firm currently has an &#34;outperform&#34; rating on the medical equipment provider's stock. Evercore ISI's target price points to a potential upside of 6.61% from the company's current price.<div>Get Align Technology alerts:</div><ul><li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li></ul>Other equities research analysts have also recently issued research reports about the company. Piper Sandler upped their price target on Align Technology from $200.00 to $220.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday. Barclays started coverage on shares of Align Technology in a research note on Monday, December 8th. They issued an &#34;equal weight&#34; rating and a $170.00 price objective on the stock. UBS Group upped their price objective on shares of Align Technology from $175.00 to $185.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday. Jefferies Financial Group lifted their target price on shares of Align Technology from $155.00 to $185.00 and gave the company a &#34;hold&#34; rating in a report on Thursday. Finally, Weiss Ratings raised shares of Align Technology from a &#34;sell (d+)&#34; rating to a &#34;hold (c-)&#34; rating in a report on Friday, January 16th. Seven analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of &#34;Hold&#34; and a consensus target price of $195.92.Check Out Our Latest Analysis on ALGN<h2>Align Technology Stock Performance</h2><ul><li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li></ul>Shares of NASDAQ:ALGN opened at $187.60 on Thursday. Align Technology has a one year low of $122.00 and a one year high of $224.18. The stock has a market capitalization of $13.46 billion, a price-to-earnings ratio of 33.14, a PEG ratio of 1.97 and a beta of 1.84. The company has a 50-day simple moving average of $163.26 and a 200-day simple moving average of $148.77. Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.30. The firm had revenue of $1.05 billion for the quarter, compared to analysts' expectations of $1.03 billion. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The firm's revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.44 EPS. As a group, research analysts forecast that Align Technology will post 7.98 EPS for the current fiscal year. <h2>Institutional Inflows and Outflows</h2><ul><li>MarketBeat Week in Review: 12/25 - 12/29</li></ul>Several institutional investors and hedge funds have recently added to or reduced their stakes in ALGN. Atria Investments Inc raised its holdings in shares of Align Technology by 4.9% in the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider's stock worth $298,000 after acquiring an additional 74 shares during the last quarter. Comerica Bank increased its position in Align Technology by 0.6% during the 4th quarter. Comerica Bank now owns 13,656 shares of the medical equipment provider's stock worth $2,132,000 after purchasing an additional 76 shares in the last quarter. IFP Advisors Inc raised its stake in Align Technology by 5.7% in the 2nd quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider's stock valued at $270,000 after purchasing an additional 77 shares during the last quarter. Arizona State Retirement System raised its stake in Align Technology by 0.4% in the 3rd quarter. Arizona State Retirement System now owns 20,387 shares of the medical equipment provider's stock valued at $2,553,000 after purchasing an additional 79 shares during the last quarter. Finally, Sentry Investment Management LLC lifted its holdings in Align Technology by 73.1% in the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 79 shares in the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds. <h2>Key Align Technology News</h2>Here are the key news stories impacting Align Technology this week:<ul> Please show the positive items first, then the neutral items, and finally the negative items. <li>Positive Sentiment: Q4 results beat consensus — EPS $3.29 vs $2.99 est and revenue $1.05B vs $1.03B; management highlighted strong demand for clear aligners which drove record Invisalign volumes, a primary driver of the stock rally. Align Technology beats fourth-quarter results estimates on dental products demand</li> <li>Positive Sentiment: Major analyst price-target increases from Leerink (to $225) and Mizuho (to $215) boost upside perception and reflect analyst model upgrades after the quarter. Leerink Partners adjusts Align Technology PT to $225 Mizuho adjusts price target on Align Technology to $215</li> <li>Positive Sentiment: CEO Joseph Hogan framed the macro/demand backdrop as more stable and cited rising teen and international demand — supportive commentary for forward growth expectations. The markets are ‘more stable than what we experienced in the past,' says Align Technology CEO</li> <li>Neutral Sentiment: Company set a modest 2026 revenue growth target of 3%–4% and issued Q1 revenue guidance roughly in line with Street estimates — suggests steady but not accelerating top-line growth. Align Technology outlines 3-percent–4-percent revenue growth target for 2026</li> <li>Neutral Sentiment: Analyst ratings are mixed: Jefferies raised its PT to $185 but kept a &#34;hold,&#34; and Morgan Stanley moved its PT to $169 with an &#34;equal weight&#34; stance — shows divergence in conviction despite upgrades. Jefferies co adjusts Align Technology price target to $185 Morgan Stanley raises price target</li> <li>Negative Sentiment: Margins declined in the quarter — gross and operating margins fell despite the volume beat, a profitability headwind that could limit multiple expansion if trends persist. ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down</li> </ul><h2>About Align Technology</h2> (Get Free Report)Align Technology, Inc NASDAQ: ALGN pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions. The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.<h2>Featured Articles</h2><ul><li>Five stocks we like better than Align Technology</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>The day the gold market broke</li><li>What a Former CIA Agent Knows About the Coming Collapse</li><li>Your Bank Account Is No Longer Safe</li><li>New gold price target</li></ul><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.<h2>Should You Invest $1,000 in Align Technology Right Now?</h2>Before you consider Align Technology, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.While Align Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here </div>

ALGN

Evercore ISI has raised its target price for Align Technology (NASDAQ:ALGN) from $180 to $200, maintaining an "outperform" rating. This suggests a potential upside of 6.61% from the current price. Other analysts have also increased their price targets, with Piper Sandler setting it at $220 and UBS at $185. Align Technology reported strong Q4 earnings, with EPS of $3.29, exceeding estimates, and revenue of $1.05 billion. The stock has a market cap of $13.46 billion and is primarily held by institutional investors.

Market Beat

Evercore ISI Forecasts Strong Price Appreciation for Align Technology (NASDAQ:ALGN) Stock